Status: current, Defined. Date: 28-Feb 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4671011000168112 | Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) (amlodipine 5 mg + hydrochlorothiazide 12.5 mg + olmesartan medoxomil 20 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4671021000168117 | Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet | Is a | olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet | true | Inferred relationship | Some | ||
| Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet | Is a | Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) | true | Inferred relationship | Some | ||
| Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet | has intended active ingredient | hydrochlorothiazide | true | Inferred relationship | Some | 1186800414 | |
| Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet | has Australian BoSS | hydrochlorothiazide | true | Inferred relationship | Some | 1186800414 | |
| Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet | has Australian BoSS | olmesartan medoxomil | true | Inferred relationship | Some | 563527479 | |
| Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet | has intended active ingredient | olmesartan | true | Inferred relationship | Some | 563527479 | |
| Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet | has Australian BoSS | amlodipine | true | Inferred relationship | Some | 1630555975 | |
| Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet | has intended active ingredient | amlodipine | true | Inferred relationship | Some | 1630555975 | |
| Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet | has unit of use | tablet | true | Inferred relationship | Some | 255565703 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet, 30, blister pack | has TPUU | True | Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet | Inferred relationship | Some | 1257828439 |
| Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet, 10, blister pack | has TPUU | True | Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet | Inferred relationship | Some | 1819888813 |
| Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet, 30 | has TPUU | True | Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet | Inferred relationship | Some | 350781064 |
| Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet, 10 | has TPUU | True | Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet | Inferred relationship | Some | 866468980 |
Reference Sets
Trade product unit of use reference set
FHIR